These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1215 related items for PubMed ID: 19161416

  • 1. The roles of IL-17A in inflammatory immune responses and host defense against pathogens.
    Iwakura Y, Nakae S, Saijo S, Ishigame H.
    Immunol Rev; 2008 Dec; 226():57-79. PubMed ID: 19161416
    [Abstract] [Full Text] [Related]

  • 2. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.
    Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y.
    Immunity; 2009 Jan 16; 30(1):108-19. PubMed ID: 19144317
    [Abstract] [Full Text] [Related]

  • 3. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA, Wright JF, Dunussi-Joannopoulos K, Collins M.
    Immunol Rev; 2008 Dec 16; 226():87-102. PubMed ID: 19161418
    [Abstract] [Full Text] [Related]

  • 4. RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.
    Leppkes M, Becker C, Ivanov II, Hirth S, Wirtz S, Neufert C, Pouly S, Murphy AJ, Valenzuela DM, Yancopoulos GD, Becher B, Littman DR, Neurath MF.
    Gastroenterology; 2009 Jan 16; 136(1):257-67. PubMed ID: 18992745
    [Abstract] [Full Text] [Related]

  • 5. Th17 cytokines and mucosal immunity.
    Dubin PJ, Kolls JK.
    Immunol Rev; 2008 Dec 16; 226():160-71. PubMed ID: 19161423
    [Abstract] [Full Text] [Related]

  • 6. Targeting the development and effector functions of TH17 cells.
    Ghilardi N, Ouyang W.
    Semin Immunol; 2007 Dec 16; 19(6):383-93. PubMed ID: 18083530
    [Abstract] [Full Text] [Related]

  • 7. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
    Lubberts E.
    Cytokine; 2008 Feb 16; 41(2):84-91. PubMed ID: 18039580
    [Abstract] [Full Text] [Related]

  • 8. IL-17-producing T cells in lung immunity and inflammation.
    Nembrini C, Marsland BJ, Kopf M.
    J Allergy Clin Immunol; 2009 May 16; 123(5):986-94; quiz 995-6. PubMed ID: 19410688
    [Abstract] [Full Text] [Related]

  • 9. IL-17A is produced by Th17, gammadelta T cells and other CD4- lymphocytes during infection with Salmonella enterica serovar Enteritidis and has a mild effect in bacterial clearance.
    Schulz SM, Köhler G, Holscher C, Iwakura Y, Alber G.
    Int Immunol; 2008 Sep 16; 20(9):1129-38. PubMed ID: 18599501
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel heterodimeric cytokine consisting of IL-17 and IL-17F regulates inflammatory responses.
    Chang SH, Dong C.
    Cell Res; 2007 May 16; 17(5):435-40. PubMed ID: 17452998
    [Abstract] [Full Text] [Related]

  • 14. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y, Shen F, Crellin NK, Ouyang W.
    Ann N Y Acad Sci; 2011 Jan 16; 1217():60-76. PubMed ID: 21155836
    [Abstract] [Full Text] [Related]

  • 15. Understanding the IL-23-IL-17 immune pathway.
    McKenzie BS, Kastelein RA, Cua DJ.
    Trends Immunol; 2006 Jan 16; 27(1):17-23. PubMed ID: 16290228
    [Abstract] [Full Text] [Related]

  • 16. IL-17 is necessary for host protection against acute-phase Trypanosoma cruzi infection.
    Miyazaki Y, Hamano S, Wang S, Shimanoe Y, Iwakura Y, Yoshida H.
    J Immunol; 2010 Jul 15; 185(2):1150-7. PubMed ID: 20562260
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-12 family members and type I interferons in Th17-mediated inflammatory disorders.
    Goriely S, Cavoy R, Goldman M.
    Allergy; 2009 May 15; 64(5):702-9. PubMed ID: 19383026
    [Abstract] [Full Text] [Related]

  • 18. Functional specialization of interleukin-17 family members.
    Iwakura Y, Ishigame H, Saijo S, Nakae S.
    Immunity; 2011 Feb 25; 34(2):149-62. PubMed ID: 21349428
    [Abstract] [Full Text] [Related]

  • 19. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells.
    Holm CK, Petersen CC, Hvid M, Petersen L, Paludan SR, Deleuran B, Hokland M.
    J Immunol; 2009 Oct 01; 183(7):4422-31. PubMed ID: 19748983
    [Abstract] [Full Text] [Related]

  • 20. Diseases that may benefit from manipulating the Th17 pathway.
    Miossec P.
    Eur J Immunol; 2009 Mar 01; 39(3):667-9. PubMed ID: 19283719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 61.